Compare · ASML vs EKSO
ASML vs EKSO
Side-by-side comparison of ASML Holding N.V. New York Registry Shares (ASML) and Ekso Bionics Holdings Inc. (EKSO): market cap, price performance, sector, and recent activity on the wire.
Summary
- ASML operates in Technology, while EKSO operates in Industrials - the two are in different parts of the market.
- ASML is the larger of the two at $621.59B, about 14782.8x EKSO ($42.0M).
- Over the past year, ASML is up 119.0% and EKSO is up 165.0% - EKSO leads by 46.0 points.
- EKSO has been more active in the news (19 items in the past 4 weeks vs 1 for ASML).
- ASML has more recent analyst coverage (25 ratings vs 0 for EKSO).
- Company
- ASML Holding N.V. New York Registry Shares
- Ekso Bionics Holdings Inc.
- Price
- $1613.47+0.52%
- $11.37-1.52%
- Market cap
- $621.59B
- $42.0M
- 1M return
- +15.74%
- +22.26%
- 1Y return
- +118.99%
- +165.03%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1995
- News (4w)
- 1
- 19
- Recent ratings
- 25
- 0
ASML Holding N.V. New York Registry Shares
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection related systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to measure the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and software solutions to create applications that enhance the setup of the lithography system; and mature products and services that refurbish used lithography equipment and offers associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, the Netherlands, Europe, the Middle East, Africa, the United States, and rest of Asia. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Ekso Bionics Holdings Inc.
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.
Latest ASML
- ASML reports transactions under its current share buyback program
- ASML reports transactions under its current share buyback program
- SEC Form 6-K filed by ASML Holding N.V. New York Registry Shares
- ASML discloses 2026 AGM results
- SEC Form 6-K filed by ASML Holding N.V. New York Registry Shares
- ASML reports €8.8 billion total net sales and €2.8 billion net income in Q1 2026
- ASML reports transactions under its current share buyback program
- SEC Form 6-K filed by ASML Holding N.V. New York Registry Shares
- ASML publishes agenda Annual General Meeting 2026
- SEC Form 20-F filed by ASML Holding N.V. New York Registry Shares
Latest EKSO
- Amendment: Ekso Bionics Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Director Cummins Wes was granted 200,000 shares (SEC Form 4)
- Director Miller Douglas S was granted 200,000 shares (SEC Form 4)
- Director Benson Ella G. was granted 200,000 shares (SEC Form 4)
- Director Nottenburg Richard N was granted 200,000 shares (SEC Form 4)
- Chief Financial Officer Wong Jerome was granted 40,000 shares, increasing direct ownership by 161% to 64,771 units (SEC Form 4)
- Director Davis Scott G. was granted 109,357 shares, increasing direct ownership by 139% to 188,134 units (SEC Form 4)
- Director Clancy William M was granted 200,000 shares (SEC Form 4)
- SEC Form 3 filed by Ekso Bionics Holdings Inc.
- SEC Form 3 filed by Ekso Bionics Holdings Inc.